- Report
- September 2022
- 240 Pages
Global
From €4861EUR$5,550USD£4,219GBP
- Report
- October 2020
- 220 Pages
North America
From €5211EUR$5,950USD£4,523GBP
- Report
- January 2024
- 160 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- May 2021
- 120 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- August 2023
- 145 Pages
Global
From €2759EUR$3,150USD£2,395GBP
- Report
- July 2024
- 200 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- July 2023
- 444 Pages
Global
From €3153EUR$3,600USD£2,737GBP
- Report
- July 2023
- 186 Pages
Middle East, Africa
From €1314EUR$1,500USD£1,140GBP
- Report
- April 2023
- 109 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- January 2024
- 91 Pages
Global
From €3500EUR$4,281USD£3,144GBP
The Electroporator market is a subset of the biotechnology industry that focuses on the development and sale of electroporation devices. Electroporation is a process used to introduce foreign material into cells, such as DNA, by applying a brief electric pulse. This process is used in a variety of biotechnological applications, such as gene therapy, gene editing, and vaccine production. Electroporators are used to generate the electric pulse, and come in a variety of sizes and configurations.
The Electroporator market is highly competitive, with a number of companies offering a range of products. These companies include Bio-Rad Laboratories, Biosan, Corning, Eppendorf, Lonza, and Thermo Fisher Scientific. Show Less Read more
